• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Par Drugs & Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 66408.0
  • ISIN : INE04LG01015
98.90 0 (-0.40%)
  • As on 01 Aug 2026 (EOD)

  • Today’s Low

    97.05

  • Today’s High

    103.00

  • Open

    99.30

  • Perv Close

    99.30

  • 52W Low

    78.05

  • 52W High

    122.43

Key Indicators

  • P/E(TTM)

    9.29

  • Mar.Cap (₹Cr.)

    121.69

  • Div & Yield %

    0.00

  • Book Value(₹)

    91.01

  • Debt-Equity Ratio

    -0.40

  • AGM Date

    31-Jul-2026

  • EPS

    10.65

  • P/E Ratio

    9.29

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    121.69

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.30

  • BV (₹)

    91.00

  • Sales( ₹ in Cr.)

    103.66

  • NP (in Cr.)

    13.11

  • NP Var(%)

    4.0

  • Div%

    0.0

  • CPS (₹)

    13.70

  • EPS (₹)

    10.70

  • Traded Value (₹ in Lakhs)

    121.69

  • 52 Week High

    122.43

  • 52 Week Low

    78.05

  • Price BSE

    0.0

  • Price NSE

    99.00

  • Market Capital( in Cr.)

    121.69

  • P/C Ratio

    7.20

  • P/E Ratio

    9.30

  • Price Vs.BV

    10.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 113.39 107.26 95.75 84.85 69.07 55.84
Excise Duty 12.42 11.62 0.00 9.78 8.32 0.00
Net Sales 100.97 95.64 95.75 75.07 60.75 55.84
Other Income 2.15 0.24 0.24 0.18 2.18 0.10
Stock Adjustments 1.28 -0.47 0.70 0.79 0.21 -1.46
Total Income 104.40 95.41 96.69 76.04 63.14 54.48
EXPENDITURE :            
Raw Materials 39.41 33.32 41.03 29.61 22.09 22.19
Power and Fuel Cost 19.49 16.40 17.83 13.49 9.82 10.70
Employee Cost 5.85 5.50 4.89 4.10 3.98 4.11
Other Manufacturing Expenses 6.01 5.57 4.68 4.02 3.43 3.16
Selling and Administration Expenses 11.63 10.16 9.60 8.22 5.62 4.58
Miscellaneous Expenses 0.36 1.40 0.22 0.16 0.01 0.18
Employee Benefit Expenses 5.85 5.50 4.89 4.10 3.98 4.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 82.75 72.35 78.25 59.61 44.95 44.93
Operating Profit 21.65 23.06 18.44 16.43 18.19 9.54
Interest 0.08 0.11 0.13 0.45 0.64 0.79
Gross Profit 21.57 22.95 18.31 15.98 17.55 8.75
Depreciation 3.65 3.44 3.23 3.28 2.82 2.76
Profit Before Tax 17.92 19.51 15.08 12.70 14.73 5.99
Current Tax 4.53 4.98 3.80 3.35 3.36 1.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.04 0.04 -0.05 0.14 -0.25 0.23
Reported Net Profit 13.36 14.50 11.33 9.21 11.61 4.76
Extraordinary Items 0.79 0.01 0.11 0.00 1.53 0.02
Adjusted Net Profit 12.57 14.49 11.22 9.21 10.08 4.74
Adjustment below Net Profit -0.02 -0.11 0.03 -0.01 -0.01 -0.01
P & L Balance brought forward 62.55 48.16 36.80 29.13 17.53 14.48
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 1.54 0.00 1.70
P & L Balance carried down 75.89 62.55 48.16 36.80 29.13 17.53
Dividend 0.00 0.00 0.00 1.54 0.00 1.54
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 25.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 2.50
Earnings Per Share-Unit Curr 10.86 11.79 9.21 7.49 18.87 7.75
Earnings Per Share(Adj)-Unit Curr 10.86 11.79 9.21 7.49 9.44 3.88
Book Value 80.44 69.59 57.90 48.66 84.87 66.02
Book Value(Adj)-Unit Curr 80.44 69.59 57.90 48.66 42.44 33.01

Shareholding Pattern

  • Promoter Group

    73.41%

  • Public Share Holding

    26.59%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,032,750 73.41 9,032,750 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,032,750 73.41 9,032,750 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,465 0.09 10,465 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,465 0.09 10,465 1
2] Non Institution
Bodies Corporate 400,604 3.26 400,604 26
Clearing Members 912 0.01 912 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 131,554 1.07 131,554 124
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 152,087 1.24 152,087 176
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 166,769 1.36 166,769 5
Individuals holding nominal share capital up to Rs. 1 lakh 2,287,553 18.59 2,287,553 12,436
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,261,421 26.51 3,261,421 12,775
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,304,636 100.00 12,304,636 12,782

Company Background

Par Drugs & Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Par Drugs & Chemicals Ltd
  • BSE Code : 66408.0
  • ISIN : INE04LG01015

  • Incorporation Year

    1999

  • Registered Office

    805 Dwarkesh Complex
    RC Dutt Road Alkapuri, Vadodara,
    Gujarat-390007

  • Telephone

    91-265-2332018

  • FAX

  • Chairman

    FALGUN VALLABHBHAI SAVANI

  • Managing Director

  • Company Secretary

    Sanket Bhupendrabhai Trivedi

  • Auditor

    Sarupriya Somani & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Par Drugs & Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Par Drugs & Che. 98.90 103.12 113.39 9.29 19.48
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77